The Corneal Comeback
Amid a global donor shortage, the pioneering CALEC therapy is transforming corneal regeneration, offering new hope for sight restoration A…
Opus Genetics’ VEGA-3 Trial Hits Primary Endpoint for Phentolamine 0.75% for Presbyopia
Phentolamine 0.75% improved near vision at 12 hours post-dose on Day 8. Opus Genetics (North Carolina, United States) has announced…
latest posts
